Niger news and features

Kenya becomes the first country to protect girls against cervical cancer with GAVI-supported human papillomavirus (HPV) vaccines.

Historic agreements show power of innovative public-private partnership

More than 180,000 girls in eight developing countries are set to receive protection against the leading cause of cervical cancer thanks to human papillomavirus (HPV) vaccines funded by the GAVI Alliance.

In its first ever Multilateral Organisation Performance Assessment Network (MOPAN) review the GAVI Alliance has been commended for its effectiveness in increasing access to immunisation and for its focus on results.

A revolutionary meningitis vaccine will reach the 100 millionth person this week in a region of Africa that has been plagued by deadly epidemics for more than a century. The milestone will take place in northern Nigeria, part of Africa’s “meningitis belt’, where the country is conducting its second seasonal immunisation campaign against the disease.

Useful information for anyone attending the Partners' Forum in Tanzania: Climate, Passports & Visas, Health, Safety, General behaviour in public, Currency, Tipping, Electricity, Shopping

Efforts to eliminate meningitis in 26 at-risk countries will take a major step forward over the next three months as 50 million people receive crucial vaccinations in seven African countries.

Rotavirus vaccines will protect children from severe and deadly diarrhoea.

Interview with Muhammad Sani Adamu, Head of Accelerated Disease Control in Nigeria’s National Primary Health Care Development Agency, who played a key role in rolling out the new vaccine against meningitis A, MenAfriVac, to Nigeria’s northern states.

One of the first countries to introduce the new meningitis A vaccine (MenAfriVac), Chad ran an immunisation campaign with GAVI support in December 2011 to help eliminate the region’s devastating epidemics.